Plasma therapy reduce to increase the risk of Covid-19

Plasma therapy reduce to increase the risk of Covid-19

In plasma therapy, antibodies from a person’s blood that have been recovered from the coronavirus and transferred to a coronavirus infected patient to boost the immune system to fight infection.

Plasma therapy for COVID-19 neither reduces the risk of death nor does it slow the progression of the disease from mild to severe, said The Medical Council of Medical Research in a study.

In plasma therapy, antibodies from a person’s blood that have been recovered from the coronavirus and transferred to a coronavirus infected patient to boost the immune system to fight infection.

The Council of Medical Research of India (ICMR) tested 464 moderately ill patients with difficulty breathing and oxygen saturation levels below 93 percent. They were divided into two groups – 235 were given plasma while 229 received only standard care. The intervention group (235 patients) was transfused with two doses of 200 ml plasma over 24 hours. Both the intervention and control groups were compared after 28 days.

A total of 34 patients or 13.6 percent who received plasma therapy did not die, the top medical body said, while 31 patients or 14.6 percent who did not receive plasma died. The study states that 17 patients in each group have a serious illness.

However, plasma therapy had a slight benefit in reducing symptoms such as shortness of breath and fatigue and had no effect on other symptoms such as fever and cough.

Many states like Delhi, Odisha, Maharashtra and Tamil Nadu are conducting plasma therapy to deal with coronavirus outbreaks. In Delhi, plasma therapy has been given to more than 700 patients and has been widely publicized by the Delhi government.

Government officials did not respond to a request for comment on the study.

Meanwhile, doctors and experts said they have seen the benefits of plasma therapy in treating coronavirus patients.

Head of the Institute of Liver and Biliary Sciences, Dr. SK Sareen – who conducted Delhi’s first plasma therapy trial and also has a plasma bank – said: “The study conducted by ICMR does not mean that all the gates are now closed for plasma therapy. The study also states that There are definite benefits and no adverse effects. ICMR’s own study states that this helped with symptoms such as shortness of breath and fatigue. “

In the U.S., 65,000 people have been given plasma therapy and it is still ongoing, he said. “If an advanced nation like the US is giving plasma therapy to such a large number of people, there is definitely an advantage somewhere. Tests by the FDA in the US have shown that plasma therapy can reduce mortality by up to 35 percent. Does. “

Medical Director and Principal Investigator of Plasma Therapy at LNJP Hospital, Delhi, Dr. Suresh Kumar said: “We cannot question the ICMR test. But we have administered it to 114 patients. We gave it an oxygen saturation level just below 93 per cent. And it has an oxygen level of 85 to 95 per cent. In others, the fever subsided and in some cases the respiratory rate returned to normal. “

LNJP Hospital is the largest COVID-19 dedicated facility of the Delhi Government and so far, more than 3,000 patients have been recovered from coronavirus and discharged from the hospital.

Medical Director Dr. Rajiv Gandhi Superspeciality Hospital. BL Sherwal said: “We are conducting it on 88 patients and the study is still ongoing. It does not have adverse effects and it is very important. Even ICMR does not say that therapy is adverse. Effects. “Even if there are minor benefits, we can look at it and see how it can play a role in relieving patients.”

Last month the World Health Organization was cautious about the use of plasma in recovered COVID-19 patients to treat those who say it is sick, works “low quality”.

admin

admin

One thought on “Plasma therapy reduce to increase the risk of Covid-19

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: